The Maternal Mental Health Market size was valued at USD 10.15 billion in 2024 and is expected to reach USD 75.29 billion by 2032, growing at a CAGR of 28.61% over the forecast period of 2025-2032.
To Get more information on Maternal Mental Health Market - Request Free Sample Report
The rising government funding, increasing awareness, and policies to reduce maternal mortality and improve the mental health of mothers have been propelling the growth of the maternal mental health market exponentially. The increasing number of innovations in treatment further propel the market growth.
The U.S. FDA approved zuranolone in 2023, the first oral drug for postpartum depression offering a fast-acting, outpatient solution. Lipocine Inc. is also developing LPCN 1154, which may become the fastest-acting oral therapy for PPD.
These developments reflect growing commitment and opportunity in maternal mental healthcare. Supportive regulatory measures, such as Medicaid expansion under the Affordable Care Act, have also played a key role. Over 38 U.S. states and Washington, D.C., now provide extended postpartum coverage beyond the traditional 60-day limit.
The U.S. maternal mental health market has witnessed significant growth, it’s projected to reach USD 24.24 billion by 2032, growing at a significant CAGR. This rise has also been linked to improved awareness, expanded screening practices, and better access to specialty mental health care for women during and after pregnancy. Mental health conditions and substance use disorders are among the most prevalent pregnancy complications in the United States, with approximately 1 in 5 women affected each year.
The U.S. Department of Health and Human Services is prioritizing maternal mental health with a task force and a national strategy that aims to increase screening, prevention, and access to care. In 2023 alone, 15 states were able to pass new maternal mental health laws, signaling a national commitment to tackle this critical public health issue.
Drivers:
Increased Awareness of the Postpartum Mental Health to Boosts Early Diagnosis and drive the Market Growth
The growing awareness about postpartum depression (PPD), anxiety, and other perinatal mental health disorders has helped mothers achieve rates of early diagnosis and health-seeking behaviour. Public health campaigns, digital content, and maternal education programs have begun to shatter the stigma that once kept so many women quiet. More and more women are also recognizing symptoms sooner and actively seeking medical attention, therapy, and emotional support.
This trend is being accelerated globally by awareness campaigns organized by NGOs, government health departments, or healthcare providers. Postnatal mental health has lost its taboo status, it’s now addressed more openly in both public and clinical settings.
This has led to an increased need for healthcare providers to recognize and properly manage these ailments. This knowledge tracks with insurers, who are increasingly covering perinatal mental health care. Social media has been used extensively to connect mothers with similar experiences and support groups. These dynamics are driving demand for maternal mental health solutions. Engagement with startups and digital health platforms that provide therapy, mindfulness, and psychological assessment is surging. Celebrities and influencers speaking openly about their postpartum mental health challenges have also given these experiences credibility, which has made it easier for everyday women to own their needs.
Restraints
Shortage of qualified maternal mental health professionals hinders maternal mental health market growth
The lack of more trained mental health professionals who can provide care for mothers has created a critical bottleneck to early diagnosis and effective treatment. Yet where the knowledge of perinatal mental disorders is lacking, so are the diagnoses; it remains lost on the majority of women. General practitioners and obstetricians often lack training in this niche area, resulting in underreporting and delayed interventions. In rural and remote areas, the problem becomes even more acute, where access to any form of psychiatric or psychological treatment is sparse or absent altogether. These areas have limited healthcare infrastructure, and often have little or no provision for maternal-focused mental health care. This inability to treat these various populations is exacerbated by the dearth of culturally relevant mental health training. The shortage also affects follow-up care, when patients require long-term counseling and monitoring, which is often in short supply.
By Disease Indication
In 2024, pregnancy and postpartum anxiety held the maternal mental health market share at 35%. This prominence is attributed to the understanding and awareness gained of perinatal mental health issues, which include anxiety disorders. Growth has also been attributed to government initiatives playing an important role.
For instance, the Health Resources and Services Administration (HRSA) within the U.S. Department of Health and Human Services launched the Maternal Mental Health Hotline in May 2022 to assist new mothers with mental health issues, and this line is operational 24/7 to provide support.
Additionally, requested Fiscal Year 2023 Budgetary funding enhanced this service for more staffing and capacity. Further, the Affordable Care Act requires insurance plans to cover preventive services, including screening for maternal depression, at no cost to the patient, thus enabling early identification and intervention. This has greatly supported the much-publicized pregnancy and postpartum anxiety segment in the market.
Meanwhile, the postpartum depression (PPD) segment is projected to grow at the fastest CAGR. The CDC states that about one in eight women in the U.S. report PPD symptoms. Regulatory frameworks such as the Affordable Care Act have strengthened support by mandating insurance coverage for preventive care services such as maternal depression screening. Awareness campaigns and support programs further contribute to the rising demand for maternal mental health services.
By Therapy
The interpersonal psychotherapy (IPT) segment accounted for a significant share of 19% In 2024, and is projected to grow with the fastest annual growth rate during the forecast period. IPT is a brief and focal therapy to improve interpersonal relationships and social functioning to alleviate stress. Most professional bodies, including the American Psychiatric Association and the American College of Obstetricians and Gynecologists, acknowledge its use in the treatment of perinatal mood disorders, including postpartum anxiety and depression. Government backing has improved the general IPT usage.
For example, although the Department of Health and Human Services has stressed evidence-based interventions for maternal mental health, it has also provided access to funds and resources for IPT. These are some of the characteristics of the high market share of IPT.
In 2023, North America dominated the maternal mental health market, accounting for 41% of the global revenue. This is because there are several factors, such as the high prevalence of maternal mental health disorders, healthcare infrastructure, and government initiatives in this area.
For instance, the U.S. launches programs such as the Maternal Mental Health Hotline and extends Medicaid to enable better access to maternal mental care.
In addition, the U.S. Department of Health and Human Services also inaugurated in February 2025 the HHS Secretary's Postpartum Maternal Health Collaborative to improve maternal and child health in rural settings, making its contribution to the region's stronghold in the market.
The U.S. government’s comprehensive national strategy, launched in 2023, promotes maternal mental health as a public health issue. It has led to increased federal funding, wider screening programs, and the establishment of specialized clinics. At the state level, during 2023 alone, 15 states created new maternal mental health laws that opened more doors to care and reduced barriers for underserved populations. Through these policy cases, the market will grow quite fast with a very good rate of diagnosis and treatment.
Asia Pacific is the fastest-growing region with around 29.28% CAGR during the forecast period. This growth is attributed to rising awareness, shifting attitudes toward perinatal mental health, and substantial investments in healthcare infrastructure. Traditionally, stigma and limited resources constrained access to mental health care, but recent years have seen increased government and private sector involvement in establishing specialized services, such as counseling centers and perinatal psychiatric units. The integration of telemedicine and digital health platforms is further improving access, especially in rural and underserved areas.
Europe held a significant share of the maternal mental health market, supported by well-established healthcare systems and comprehensive maternal care policies. The region benefits from ongoing awareness campaigns and government programs aimed at early detection and intervention for maternal mental health disorders. The market is characterized by a high adoption rate of digital health solutions, cross-border collaborations, and the presence of major pharmaceutical and healthcare technology companies.
Recent moves, such as Maven Clinic’s acquisition of Naytal, are expanding the reach of digital maternal mental health services across the continent. Western European countries, particularly the UK, Germany, and France, are leading in both innovation and service provision.
The LAMEA region, encompassing Latin America, the Middle East, and Africa, is experiencing steady growth in the maternal mental health market. In Latin America, the market was driven by increasing awareness and improvements in maternal care services. The Middle East & Africa are driven by the rising demand for comprehensive maternal care, government health initiatives, and the adoption of telemedicine to bridge gaps in access. However, socioeconomic disparities and limited healthcare infrastructure remain challenges, particularly in rural and underserved communities.
Get Customized Report as per Your Business Requirement - Enquiry Now
Mammha, Seleni Institute, Canopie, LunaJoy, Maternity Foundation, UNFPA, Therapy Mama, Brightside Health Inc., March of Dimes, Viatris Inc., GSK plc, Alembic Pharmaceuticals Limited, Mallinckrodt, Sage Therapeutics, Inc., Bausch Health Companies Inc., Magellan Health, Inc., Pfizer Inc., Eli Lilly and Company
In Jan 2025, LunaJoy Health raised $4.2M to fund the rollout of LunaCare, an AI-driven maternal mental health program for Medicaid moms, embedding care into current systems.
In April 2024, LunaJoy overhauled its clinician certification process with real recordings and AI-simulated cases, with plans to make them accessible for more people and provide CE/CME credits.
In February 2023, Biogen Inc. and Sage Therapeutics, Inc. announced that the FDA accepted for filing the New Drug Application for zuranolone, a novel therapy for postpartum depression and major depressive disorder. The application received priority review, with an FDA action date set for August 5, 2023.
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 10.15 Billion |
| Market Size by 2032 | USD 75.29 Billion |
| CAGR | CAGR of 28.6 From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Disease Indication (Postpartum Depression, Dysthymia, Birth-Related PTSD, Pregnancy and Postpartum General Anxiety, Pregnancy and Postpartum OCD, Others), • By Therapy (Antidepressants, Cognitive Behavioral Therapy (CBT), Interpersonal Psychotherapy (IPT), Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Mammha, Seleni Institute, Canopie, LunaJoy, Maternity Foundation, UNFPA, Therapy Mama, Brightside Health Inc., March of Dimes, Viatris Inc., GSK plc, Alembic Pharmaceuticals Limited, Mallinckrodt, Sage Therapeutics, Inc., Bausch Health Companies Inc., Magellan Health, Inc., Pfizer Inc., AstraZeneca, Eli Lilly and Company, Happify Health. |
Ans. The projected market size for the Maternal Mental Health Market is USD 75.39 million by 2032.
Ans: The North America region dominated the Maternal Mental Health Market in 2024.
Ans. The CAGR of the Maternal Mental Health Market is 28.6% during the forecast period of 2025-2032.
Ans: Digital health technology and telepsychiatry are increasing access to maternal mental health care in underserved locations.
Ans: The pregnancy and postpartum anxiety segment dominated the Maternal Mental Health Market.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Prescription and Treatment Trends (2023), by Region
5.2 Drug Volume and Utilization Patterns
5.3 Healthcare Spending Allocation (2023)
5.4 Access to Mental Health Services
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Maternal Mental Health Market Segmentation, By Disease Indication
7.1 Chapter Overview
7.2 Postpartum Depression
7.2.1 Postpartum Depression Market Trends Analysis (2021-2032)
7.2.2 Postpartum Depression Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Dysthymia
7.3.1 Dysthymia Market Trends Analysis (2021-2032)
7.3.2 Dysthymia Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Birth-Related PTSD
7.4.1 Birth-Related PTSD Market Trends Analysis (2021-2032)
7.4.2 Birth-Related PTSD Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Pregnancy and Postpartum General Anxiety
7.5.1 Pregnancy and Postpartum General Anxiety Market Trends Analysis (2021-2032)
7.5.2 Pregnancy and Postpartum General Anxiety Market Size Estimates and Forecasts to 2032 (USD Billion)
7.6 Pregnancy and Postpartum OCD
7.6.1 Pregnancy and Postpartum OCD Market Trends Analysis (2021-2032)
7.6.2 Pregnancy and Postpartum OCD Market Size Estimates and Forecasts to 2032 (USD Billion)
7.7 Others
7.7.1 Others Market Trends Analysis (2021-2032)
7.7.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Maternal Mental Health Market Segmentation, By Therapy
8.1 Chapter Overview
8.2 Antidepressants
8.2.1 Antidepressants Market Trends Analysis (2021-2032)
8.2.2 Antidepressants Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.3 Selective serotonin reuptake inhibitors (SSRIs)
8.2.3.1 Selective serotonin reuptake inhibitors (SSRIs) Market Trends Analysis (2021-2032)
8.2.3.2 Selective serotonin reuptake inhibitors (SSRIs) Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.4 Tricyclic antidepressants (TCAs)
8.2.4.1 Tricyclic antidepressants (TCAs) Market Trends Analysis (2021-2032)
8.2.4.2 Tricyclic antidepressants (TCAs) Market Size Estimates and Forecasts to 2032 (USD Billion)
8.2.5 Others
8.2.5.1 Others Market Trends Analysis (2021-2032)
8.2.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Cognitive Behavioral Therapy (CBT)
8.3.1 Cognitive Behavioral Therapy (CBT) Market Trends Analysis (2021-2032)
8.3.2 Cognitive Behavioral Therapy (CBT) Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Interpersonal Psychotherapy (IPT)
8.4.1 Interpersonal Psychotherapy (IPT) Market Trends Analysis (2021-2032)
8.4.2 Interpersonal Psychotherapy (IPT) Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Others
8.5.1 Others Market Trends Analysis (2021-2032)
8.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Maternal Mental Health Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
9.2.3 North America Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.2.4 North America Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.2.5.2 USA Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.2.6.2 Canada Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.2.7.2 Mexico Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.3 Europe
9.3.1 Trends Analysis
9.3.2 Europe Maternal Mental Health Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
9.3.3 Europe Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.3.4 Europe Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.3.5 Germany
9.3.5.1 Germany Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.3.5.2 Germany Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.3.6 France
9.3.6.1 France Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.3.6.2 France Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.3.7 UK
9.3.7.1 UK Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.3.7.2 UK Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.3.8 Italy
9.3.8.1 Italy Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.3.8.2 Italy Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.3.9 Spain
9.3.9.1 Spain Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.3.9.2 Spain Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.3.10 Poland
9.3.10.1 Poland Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.3.10.2 Poland Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.3.11 Turkey
9.3.11.1 Turkey Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.3.11.2 Turkey Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.3.12 Rest of Europe
9.3.12.1 Rest of Europe Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.3.12.2 Rest of Europe Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Maternal Mental Health Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
9.4.3 Asia Pacific Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.4.4 Asia Pacific Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.4.5.2 China Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.4.5.2 India Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.4.5.2 Japan Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.4.6.2 South Korea Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.4.7 Singapore
9.4.7.1 Singapore Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.4.7.2 Singapore Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
8.4.8 Australia
8.4.8.1 Australia Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
8.4.8.2 Australia Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.4.9 Rest of Asia Pacific
9.4.9.1 Rest of Asia Pacific Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.4.9.2 Rest of Asia Pacific Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.5 Middle East & Africa
9.5.1 Trends Analysis
9.5.2 Middle East & Africa Maternal Mental Health Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
9.5.3 Middle East & Africa Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.5.4 Middle East & Africa Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.5.5 UAE
9.5.5.1 UAE Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.5.5.2 UAE Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.5.6 Saudi Arabia
9.5.6.1 Saudi Arabia Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.5.6.2 Saudi Arabia Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.5.7 Qatar
9.5.7.1 Qatar Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.5.7.2 Qatar Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.5.8 South Africa
9.5.8.1 South Africa Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.5.8.2 South Africa Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.5.9 Middle East & Africa
9.5.9.1 Middle East & Africa Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.5.9.2 Middle East & Africa Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Maternal Mental Health Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
9.6.3 Latin America Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.6.4 Latin America Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.6.5.2 Brazil Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.6.6.2 Argentina Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
9.6.7 Rest of Latin America
9.6.7.1 Rest of Latin America Maternal Mental Health Market Estimates and Forecasts, By Disease Indication (2021-2032) (USD Billion)
9.6.7.2 Rest of Latin America Maternal Mental Health Market Estimates and Forecasts, By Therapy Industry (2021-2032) (USD Billion)
10. Company Profiles
10.1 Mammha
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
110.1.4 SWOT Analysis
10.2 Seleni Institute
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Canopie
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 LunaJoy
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 Maternity Foundation
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 UNFPA
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Therapy Mama
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 Brightside Health Inc.
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 March of Dimes
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Viatris Inc.
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Disease Indication
Postpartum Depression
Dysthymia
Birth-Related PTSD
Pregnancy and Postpartum General Anxiety
Pregnancy and Postpartum OCD
Others
By Therapy
Antidepressants
Selective serotonin reuptake inhibitors (SSRIs)
Tricyclic antidepressants (TCAs)
Others
Cognitive Behavioral Therapy (CBT)
Interpersonal Psychotherapy (IPT)
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Poland
Turkey
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
UAE
Saudi Arabia
Qatar
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Personalized Retail Nutrition and Wellness Market size was estimated at USD 3.45 billion in 2023 and is projected to reach USD 12.58 billion by 2032.
The Endoscope Reprocessing Market is expected to grow at a 9.26% compound annual growth rate (CAGR) from 2024 to 2032, from its valuation of USD 1.62 billion in 2023 to USD 3.59 billion.
The Legionella Testing market size was USD 306.29 million in 2023 and is expected to reach USD 650.82 million by 2032 and grow at a CAGR of 8.74% over the forecast period of 2024-2032.
Disposable Blood Pressure Cuffs Market Size was valued at USD 303.9 million in 2023 and is expected to reach USD 860.16 million by 2032, growing at a CAGR of 12.27% over the forecast period 2024-2032.
The Pacemakers Market was valued at USD 5.35 Billion in 2023 and is projected to reach USD 8.77 Billion by 2032, growing at a CAGR of 5.66% from 2024 to 2032.
The Insulin Pump Market Size was valued at USD 6.70 Billion in 2023, and is expected to reach USD 13.37 Billion by 2032, and grow at a CAGR of 8.36%.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
